The Max Foundation
Tracked across 1 events · 6 articles · First seen Aug 18, 2026 · Last active Aug 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
BeOne Medicines, together with the Kashmir Care Foundation and The Max Foundation, announced the renewal of their partnership through 2028 to expand access to BRUKINSA (zanubrutinib) for the treatment of chronic lymphocytic leukemia (CLL) in…
Impact: The Max Foundation implements the oncology access programs, leveraging its expertise to deliver BRUKINSA to patients in underserved regions, and is a key partner in the renewed collaboration.
Aug 18, 2026 · 6 articles
70
BeOne Medicines renewed partnership The Max FoundationBeOne renews BRUKINSA...
60
Kashmir Care Foundation granted $1 million The Max FoundationBeOne renews BRUKINSA...
ERGEN INTELLIGENCE
Track The Max Foundation live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard